1. Home
  2. Analysis
  3. Malarone
  4. Atenolol

Malarone and Atenolol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Malarone and Atenolol. Common interactions include alopecia among females and anxiety among males.

The phase IV clinical study analyzes what interactions people who take Malarone and Atenolol have. It is created by eHealthMe based on reports of 14 people who take Malarone and Atenolol from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 27, 2022

14 people who take Malarone and Atenolol together, and have interactions are studied.

What is Malarone?

Malarone has active ingredients of atovaquone; proguanil hydrochloride. It is often used in malaria. eHealthMe is studying from 3,021 Malarone users for its effectiveness, alternative drugs and more.

What is Atenolol?

Atenolol has active ingredients of atenolol. It is often used in high blood pressure. eHealthMe is studying from 166,964 Atenolol users for its effectiveness, alternative drugs and more.

Number of Malarone and Atenolol reports submitted per year:

Malarone and Atenolol drug interactions.

Common Malarone and Atenolol drug interactions by gender *:

female:

  1. Alopecia
  2. Bladder pain
  3. Pain
  4. Urge incontinence

male:

  1. Anxiety
  2. Decreased appetite
  3. Dyspnoea
  4. Hallucination
  5. Headache
  6. Hypermetabolism
  7. Hypoaesthesia
  8. Initial insomnia
  9. Insomnia
  10. Muscle tightness

Common Malarone and Atenolol drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Electrocardiogram qt prolonged
  2. Malaise
  3. Palpitations
  4. Presyncope
  5. Supraventricular tachycardia
  6. Anxiety
  7. Cardiovascular disorder

40-49:

n/a

50-59:

  1. Arthralgia
  2. Asthma
  3. Band neutrophil count increased
  4. Blood bilirubin increased
  5. Blood glucose increased
  6. Chills
  7. Diarrhoea
  8. Eye swelling
  9. Hypersensitivity
  10. Lower respiratory tract infection

60+:

  1. Anxiety
  2. Atrial fibrillation
  3. Hallucination
  4. Headache
  5. Hypermetabolism
  6. Hypoaesthesia
  7. Initial insomnia
  8. Insomnia
  9. Muscle tightness
  10. Nocturia

Common conditions people have *:

  1. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 14.29%
  2. Food Poisoning (poison in food): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Malarone and Atenolol?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Malarone and Atenolol interactions:

Browse all drug interactions of Malarone and Atenolol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Malarone side effects:

Browse all side effects of Malarone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Atenolol side effects:

Browse all side effects of Atenolol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Atenolol interactions:

Browse all interactions between Atenolol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on atovaquone; proguanil hydrochloride and atenolol (the active ingredients of Malarone and Atenolol, respectively), and Malarone and Atenolol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Malarone and Atenolol.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.